JP2013537414A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537414A5
JP2013537414A5 JP2013523260A JP2013523260A JP2013537414A5 JP 2013537414 A5 JP2013537414 A5 JP 2013537414A5 JP 2013523260 A JP2013523260 A JP 2013523260A JP 2013523260 A JP2013523260 A JP 2013523260A JP 2013537414 A5 JP2013537414 A5 JP 2013537414A5
Authority
JP
Japan
Prior art keywords
seq
isolated
binding agent
chain polypeptide
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013523260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013537414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/046201 external-priority patent/WO2012018767A2/en
Publication of JP2013537414A publication Critical patent/JP2013537414A/ja
Publication of JP2013537414A5 publication Critical patent/JP2013537414A5/ja
Pending legal-status Critical Current

Links

JP2013523260A 2010-08-05 2011-08-02 Il−17に対する抗体 Pending JP2013537414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37097810P 2010-08-05 2010-08-05
US61/370,978 2010-08-05
PCT/US2011/046201 WO2012018767A2 (en) 2010-08-05 2011-08-02 Antibodies directed against il-17

Publications (2)

Publication Number Publication Date
JP2013537414A JP2013537414A (ja) 2013-10-03
JP2013537414A5 true JP2013537414A5 (https=) 2014-09-18

Family

ID=45560018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013523260A Pending JP2013537414A (ja) 2010-08-05 2011-08-02 Il−17に対する抗体

Country Status (10)

Country Link
US (1) US9328166B2 (https=)
EP (1) EP2601217B1 (https=)
JP (1) JP2013537414A (https=)
CN (1) CN103154026B (https=)
AU (1) AU2011285922B2 (https=)
BR (1) BR112013002831A2 (https=)
ES (1) ES2633145T3 (https=)
NZ (1) NZ607615A (https=)
RU (1) RU2595385C2 (https=)
WO (1) WO2012018767A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2577228C2 (ru) * 2014-03-14 2016-03-10 Закрытое Акционерное Общество "Биокад" Анти-il-17-антитела, способ их получения и способ применения
AR103173A1 (es) 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
CN108251431B (zh) 2015-03-05 2020-12-08 北京百特美博生物科技有限公司 双载体系统及其用途
CN109053884A (zh) * 2015-11-02 2018-12-21 东南大学 Wasabi蛋白纳米抗体及其编码序列与应用
CN107236041B (zh) * 2016-03-29 2020-07-24 舒泰神(北京)生物制药股份有限公司 Il-17抗体
CN107488227A (zh) * 2016-06-12 2017-12-19 三生国健药业(上海)股份有限公司 抗人白细胞介素‑17a单克隆抗体、其制备方法和应用
US11619832B2 (en) 2018-03-08 2023-04-04 Coopervision International Limited Identification of contact lens wearers predisposed to contact lens discomfort
JP7525499B2 (ja) 2019-01-31 2024-07-30 ヌマブ セラピューティクス アクチェンゲゼルシャフト TNFα及びIL-17Aに対する特異性を有する多重特異性抗体、IL-17Aを標的とする抗体、及びそれらの使用方法
EP3689907A1 (en) 2019-01-31 2020-08-05 Numab Therapeutics AG Antibodies targeting il-17a and methods of use thereof
EP3965818A4 (en) 2019-05-08 2023-05-31 Janssen Biotech, Inc. MATERIALS AND METHODS FOR MODULATION OF T-CELL-MEDIATED IMMUNITY
AR123935A1 (es) * 2020-10-28 2023-01-25 Janssen Biotech Inc COMPOSICIONES Y MÉTODOS PARA MODULAR LA INMUNIDAD MEDIADA POR LA CADENA d g
CN112646030B (zh) * 2021-01-11 2021-11-30 内蒙古创润生物科技有限公司 一种包含间充质干细胞外泌体的药物组合物在治疗疾病中的应用
CN121731462A (zh) * 2024-09-27 2026-03-27 百奥泰生物制药股份有限公司 抗il-17抗体制剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508214A1 (en) * 2002-12-02 2004-06-17 Abgenix, Inc. Antibodies directed to phospholipase a2 and uses thereof
GB0417487D0 (en) 2004-08-05 2004-09-08 Novartis Ag Organic compound
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101326195B9 (zh) 2005-12-13 2022-11-11 伊莱利利公司 抗il-17抗体
JP5068270B2 (ja) 2006-01-31 2012-11-07 ノバルティス アーゲー 癌を処置するためのil−17アンタゴニスト抗体
GB0612928D0 (en) * 2006-06-29 2006-08-09 Ucb Sa Biological products
CA2660463C (en) * 2006-08-11 2013-07-16 Schering Corporation Antibodies to il-17a
JP5581323B2 (ja) 2008-09-29 2014-08-27 ロシュ グリクアート アクチェンゲゼルシャフト ヒトil17に対する抗体およびその使用
WO2011056864A1 (en) 2009-11-05 2011-05-12 Anaptysbio, Inc. Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation

Similar Documents

Publication Publication Date Title
JP2013537414A5 (https=)
RU2013109397A (ru) Антитела, направленные против il-17
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
FI3841120T3 (fi) Sitrullinoituun histoni 2A:han ja/tai 4:ään sitoutuvia vasta-aineita
AR126555A2 (es) Anticuerpos de oncostatina m humana y métodos de uso
JP2014500009A5 (https=)
JP2018121657A5 (https=)
JP2018516853A5 (https=)
JP2013545438A5 (https=)
JP2019054802A5 (https=)
IL314885A (en) Anti-tl1a/anti-tnf-alpha bispecific antigen binding proteins and uses thereof
JP2014523408A5 (https=)
JP2015520169A5 (https=)
JP2012501669A5 (https=)
JP2020504101A5 (https=)
JP2012516158A5 (https=)
RU2019120720A (ru) Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином
JP2009540018A5 (https=)
JP2015504306A5 (https=)
JP2012100667A5 (https=)
RU2011101589A (ru) Антитела против il-6 и их применение
JP2019525738A5 (https=)
JP2011083291A5 (https=)
JP2017508461A5 (https=)
JP2012531922A5 (ja) Toll様受容体2へのヒト化抗体またはその抗原結合部位